212 related articles for article (PubMed ID: 24553919)
1. Transgenerational transmission of hyperactivity in a mouse model of ADHD.
Zhu J; Lee KP; Spencer TJ; Biederman J; Bhide PG
J Neurosci; 2014 Feb; 34(8):2768-73. PubMed ID: 24553919
[TBL] [Abstract][Full Text] [Related]
2. A prenatal nicotine exposure mouse model of methylphenidate responsive ADHD-associated cognitive phenotypes.
Zhu J; Fan F; McCarthy DM; Zhang L; Cannon EN; Spencer TJ; Biederman J; Bhide PG
Int J Dev Neurosci; 2017 May; 58():26-34. PubMed ID: 28179105
[TBL] [Abstract][Full Text] [Related]
3. Prenatal nicotine exposure mouse model showing hyperactivity, reduced cingulate cortex volume, reduced dopamine turnover, and responsiveness to oral methylphenidate treatment.
Zhu J; Zhang X; Xu Y; Spencer TJ; Biederman J; Bhide PG
J Neurosci; 2012 Jul; 32(27):9410-8. PubMed ID: 22764249
[TBL] [Abstract][Full Text] [Related]
4. Atomoxetine Reestablishes Long Term Potentiation in a Mouse Model of Attention Deficit/Hyperactivity Disorder.
Piña R; Rozas C; Contreras D; Hardy P; Ugarte G; Zeise ML; Rojas P; Morales B
Neuroscience; 2020 Jul; 439():268-274. PubMed ID: 31809728
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Models of Attention Deficit Hyperactivity Disorder: Neurobiology, Drug Discovery, and Beyond.
McCarthy DM; Spencer TJ; Bhide PG
J Atten Disord; 2024 Mar; 28(5):880-894. PubMed ID: 38084074
[TBL] [Abstract][Full Text] [Related]
6. Attention-Deficit/Hyperactivity Disorder-like Phenotype in a Mouse Model with Impaired Actin Dynamics.
Zimmermann AM; Jene T; Wolf M; Görlich A; Gurniak CB; Sassoè-Pognetto M; Witke W; Friauf E; Rust MB
Biol Psychiatry; 2015 Jul; 78(2):95-106. PubMed ID: 24768258
[TBL] [Abstract][Full Text] [Related]
7. Developmental nicotine exposure precipitates multigenerational maternal transmission of nicotine preference and ADHD-like behavioral, rhythmometric, neuropharmacological, and epigenetic anomalies in adolescent mice.
Buck JM; Sanders KN; Wageman CR; Knopik VS; Stitzel JA; O'Neill HC
Neuropharmacology; 2019 May; 149():66-82. PubMed ID: 30742847
[TBL] [Abstract][Full Text] [Related]
8. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
[TBL] [Abstract][Full Text] [Related]
9. GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice.
Won H; Mah W; Kim E; Kim JW; Hahm EK; Kim MH; Cho S; Kim J; Jang H; Cho SC; Kim BN; Shin MS; Seo J; Jeong J; Choi SY; Kim D; Kang C; Kim E
Nat Med; 2011 May; 17(5):566-72. PubMed ID: 21499268
[TBL] [Abstract][Full Text] [Related]
10. Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder.
Ueno K; Togashi H; Matsumoto M; Ohashi S; Saito H; Yoshioka M
J Pharmacol Exp Ther; 2002 Jul; 302(1):95-100. PubMed ID: 12065705
[TBL] [Abstract][Full Text] [Related]
11. Repetitive Mild Traumatic Brain Injury in a Perinatal Nicotine Exposure Mouse Model of Attention Deficit Hyperactivity Disorder.
Zhang L; Levenson CW; Salazar VC; McCarthy DM; Biederman J; Zafonte R; Bhide PG
Dev Neurosci; 2021; 43(1):63-72. PubMed ID: 33849015
[TBL] [Abstract][Full Text] [Related]
12. Reward-enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention-deficit/hyperactivity disorder.
Ide S; Ikekubo Y; Hua J; Takamatsu Y; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacol Rep; 2018 Sep; 38(3):149-153. PubMed ID: 30175528
[TBL] [Abstract][Full Text] [Related]
13. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
[TBL] [Abstract][Full Text] [Related]
14. Behavioral teratogenicity induced by nonforced maternal nicotine consumption.
Paz R; Barsness B; Martenson T; Tanner D; Allan AM
Neuropsychopharmacology; 2007 Mar; 32(3):693-9. PubMed ID: 16554741
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.
Soeters HS; Howells FM; Russell VA
Metab Brain Dis; 2008 Sep; 23(3):303-14. PubMed ID: 18665438
[TBL] [Abstract][Full Text] [Related]
16. Effects of clonidine and methylphenidate on motor activity in Fmr1 knockout mice.
Wrenn CC; Heitzer AM; Roth AK; Nawrocki L; Valdovinos MG
Neurosci Lett; 2015 Jan; 585():109-13. PubMed ID: 25433180
[TBL] [Abstract][Full Text] [Related]
17. The spontaneously hypertensive rat/Izm (SHR/Izm) shows attention deficit/hyperactivity disorder-like behaviors but without impulsive behavior: therapeutic implications of low-dose methylphenidate.
Kishikawa Y; Kawahara Y; Yamada M; Kaneko F; Kawahara H; Nishi A
Behav Brain Res; 2014 Nov; 274():235-42. PubMed ID: 25151620
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the effects of ABT-418 and methylphenidate on spatial memory in an animal model of ADHD.
Guo T; Yang C; Guo L; Liu K
Neurosci Lett; 2012 Oct; 528(1):11-5. PubMed ID: 22985505
[TBL] [Abstract][Full Text] [Related]
19. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
Denney CB
J Clin Child Psychol; 2001 Mar; 30(1):98-109. PubMed ID: 11294083
[TBL] [Abstract][Full Text] [Related]
20. Hyperactivity, impaired learning on a vigilance task, and a differential response to methylphenidate in the TRbetaPV knock-in mouse.
Siesser WB; Cheng SY; McDonald MP
Psychopharmacology (Berl); 2005 Oct; 181(4):653-63. PubMed ID: 15983791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
